Overview
mDETECT Inc. (Kingston) is taking precision medicine to the next level with their liquid biopsies for cancer.
What they’re doing: This genomics company has developed highly sensitive blood tests that detect six of the most common cancers (breast, prostate, lung, ovarian, pancreatic and colorectal).
How will this be used in the real world? mDETECT is working on consolidating their tests into a single-tube test that hospitals can use to see how a patient’s cancer is progressing and its response to treatment, simplifying and improving how cancer patient care is managed in Ontario.